Loading data
LABNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 85.33 m USD | 91.01 m USD | 106.34 m USD | 97.95 m USD | 130.58 m USD |
| Cost of revenue | 42.79 m USD | 46.13 m USD | 55.89 m USD | 60.9 m USD | — |
| Gross profit | 42.54 m USD | 44.88 m USD | 50.45 m USD | 37.05 m USD | — |
| Research and development expense | 25.99 m USD | 28.83 m USD | 25.95 m USD | 37.38 m USD | 37.94 m USD |
| Selling, general and administrative expense | 109.86 m USD | 103.06 m USD | 87.54 m USD | 102.29 m USD | 98.89 m USD |
| Operating profit | -110.25 m USD | -127.49 m USD | -76.6 m USD | -116.21 m USD | -67.46 m USD |
| Interest expense | — | — | 4.57 m USD | 4.33 m USD | 3.82 m USD |
| Profit before tax | -96.7 m USD | -90.4 m USD | -74.2 m USD | -192.93 m USD | -63.66 m USD |
| Income tax expense | -37.88 m USD | 542 k USD | 452 k USD | -2.83 m USD | -4.42 m USD |
| Net income (reported basis) | -74.9 m USD | -138.89 m USD | -74.66 m USD | -190.1 m USD | -59.24 m USD |
| Net income attributable to common shareholders | -74.9 m USD | -184.9 m USD | -74.66 m USD | -190.1 m USD | — |
| Basic earnings per share | -0.2 USD/share | -0.52 USD/share | -0.94 USD/share | -2.43 USD/share | -0.78 USD/share |
| Diluted earnings per share | -0.2 USD/share | -0.52 USD/share | -0.94 USD/share | -2.43 USD/share | -0.78 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.